Freezing DEI: What does this mean in terms of healthcare?

President Donald Trump recently issued an executive order titled “Ending Radical and Wasteful Government DEI Programs and Preferencing,” aiming to dismantle diversity, equity, and inclusion (DEI) initiatives within federal agencies.

This directive mandates the termination of all DEI-related policies, programs, preferences, and activities. The order also requires agencies to report on all DEI and “environmental justice” positions to the Office of Management and Budget (OMB) within 60 days.

This order has since created considerable confusion between the broadness of the executive order and the general terms in DEI.  For reference, DEI is defined as “the state of having a diverse group of participants as well as policies and norms that are equitable and inclusive. ” This includes racial and ethnic groups, gender, sexual orientation, people with disabilities, religious groups, age groups, and socioeconomic status. 

The executive order’s broad and sweeping language has led to confusion among federal agencies, contractors, and communities as they work to interpret and implement the directive. The requirement for agencies to enumerate and report all DEI-related positions, contractors, and federal grant funding has contributed to some fear and chaos, as stakeholders attempt to understand the full scope of the order’s implications. This uncertainty has resulted in a chilling effect, with some agencies and organizations preemptively halting or dismantling DEI initiatives to avoid potential non-compliance.

For instance, the Department of Health and Human Services (HHS) has been directed to cease all DEI-related activities, resulting in the suspension of programs aimed at reducing health disparities among underserved communities. Furthermore, the Food and Drug Administration (FDA) has quietly rolled back DEI initiatives, raising concerns about underrepresentation in clinical trials and the potential impact on healthcare outcomes.

Some consequences of this confusion and freeze have been recently reported in specific healthcare communities which operate with small margins.  Specifically, Community health centers in rural and underserved areas, especially those serving marginalized populations, have been notably affected. For instance, clinics in Virginia and West Virginia have faced closures or staff layoffs due to challenges in accessing essential federal funding following the implementation of the executive order.

These clinics have been forced to reduce services or shut down entirely, impacting access to primary care for approximately 400,000 patients.

In recent weeks, specifically grants supporting HIV prevention initiatives and services tailored for transgender individuals have been terminated. This has halted services and created confusion for health centers that provide HIV prevention and care for transgender patients leading to new legal challenges for future continued care. 

President Trump’s executive order to end DEI programs represents a significant policy shift from the prior administration.  It is unclear of the full effects of what will happen to these programs and who will be considered inclusive in the DEI freeze, since all federal health communications from the Centers for Disease Control and Prevention (CDC), FDA, and the National Institute of Health (NIH) were halted until the beginning of this month, leading to additional confusion.

While many argue this will eliminate wasteful spending in the federal government, others are fearful that this will undermine years of effort in working towards addressing systemic inequalities and supporting marginalized communities.

Programming note:

Listen to Tiffany Ferguson live when she reports on the social determinants of health (SDoH) Tuesdays on Talk Ten Tuesday with Chuck Buck and Angela Comfort, 10 Eastern.